
Microchip Technology Incorporated
- What it sells
- Mixed-signal Microcontrollers is 50% and Analog 28% of revenue (fiscal year to Mar 2026), from 56% and 26% two years earlier.
- Growing?
- Yes: revenue up 42% on a year earlier (quarter ended Sep 2026).
- Expensive?
- About usual: 46.7× trailing earnings; its five-year median is 27.1×. Priced 122% above the peer median of 21x.
- Analysts?
- 81% of 26 say buy; average 12-month target $86.48, 39% above today's price.
- Risky?
- Much swingier than most large companies: its price swung 53% over the past year (the S&P 500's 14%), and it fell as much as 64% since Nov 2021.
Microchip Technology Inc. designs and sells embedded control semiconductors and tools, spanning mixed-signal microcontrollers, analog (power, interface, timing/connectivity), and related “other” products, and it also runs a technology licensing business (including SuperFlash® embedded flash IP licensing).
More about Microchip Technology
Revenue is generated primarily through semiconductor product sales (via distributors and direct OEM/contract manufacturer sales) plus license fees/royalties from IP licensees.
Market Position
Microchip is a scaled supplier in the microcontroller and analog/mixed-signal markets, differentiated by broad product breadth, long product lifecycles and embedded “design-win” stickiness, plus a large ecosystem of development tools and reference designs that support customer adoption.
Key Segments
Microchip reports two operating segments: Semiconductor Products and Technology Licensing; within Semiconductor Products it discloses product lines including Mixed-signal Microcontrollers, Analog, and Other (which can include items from both semiconductor products and technology licensing).
How has the stock done?
Over the past month MCHP fell 15.9%; the semiconductor ETF (SMH) fell 15.1% and the S&P 500 fell 2.7%.
Over the past six months MCHP fell 36.5%; the semiconductor ETF (SMH) fell 10.6% and the S&P 500 rose 2.6%.
Over the past year MCHP rose 11.6%; the semiconductor ETF (SMH) rose 41.1% and the S&P 500 rose 10.8%.
Over five years MCHP fell 25.5%; the semiconductor ETF (SMH) rose 233.3% and the S&P 500 rose 62.0%.
From May 22, 2024 to Apr 8, 2025, the deepest drop from a high since Nov 2021
How much the price swings in a year; the S&P 500's was 14%
When the S&P 500 moves 1%, the stock has moved about 2.2% the same way
Show the earnings releases
| Released | Quarter | Revenue | EPS vs estimate | Stock, day after | 5 days after |
|---|---|---|---|---|---|
| Nov 5, 2026 | ended Sep 2026 | $1.6B (+42% vs a year earlier) | $0.97 vs $0.94 (beat) | −22.6% | −17.6% |
| Aug 6, 2026 | ended Jun 2026 | $1.5B (+38% vs a year earlier) | $0.76 vs $0.70 (beat) | +8.9% | −0.1% |
| May 7, 2026 | ended Mar 2026 | $1.3B (+35% vs a year earlier) | $0.57 vs $0.50 (beat) | −3.7% | −5.7% |
| Feb 5, 2026 | ended Dec 2025 | $1.2B (+16% vs a year earlier) | $0.44 vs $0.43 (beat) | −2.8% | +0.9% |
| Nov 6, 2025 | ended Sep 2025 | $1.1B (−2% vs a year earlier) | — | −7.4% | −9.9% |
| Aug 7, 2025 | ended Jun 2025 | $1.1B (−13% vs a year earlier) | — | −6.5% | −0.3% |
| May 8, 2025 | ended Mar 2025 | $970M (−27% vs a year earlier) | — | +15.1% | +26.5% |
| Feb 6, 2025 | ended Dec 2024 | $1.0B (−42% vs a year earlier) | — | −3.0% | +1.4% |
| Nov 5, 2024 | ended Sep 2024 | $1.2B (−48% vs a year earlier) | — | −1.0% | −9.6% |
| Aug 1, 2024 | ended Jun 2024 | $1.2B (−46% vs a year earlier) | — | −15.0% | −13.0% |
| May 6, 2024 | ended Mar 2024 | $1.3B (−41% vs a year earlier) | — | +0.8% | +1.3% |
| Feb 1, 2024 | ended Dec 2023 | $1.8B (−19% vs a year earlier) | — | −1.0% | −1.0% |
| Nov 2, 2023 | ended Sep 2023 | $2.3B (+9% vs a year earlier) | — | +7.6% | +3.7% |
| Aug 3, 2023 | ended Jun 2023 | $2.3B (+17% vs a year earlier) | — | −7.5% | −7.7% |
| May 4, 2023 | ended Mar 2023 | $2.2B (+21% vs a year earlier) | — | −1.4% | −4.1% |
| Feb 2, 2023 | ended Dec 2022 | $2.2B (+23% vs a year earlier) | — | +5.2% | +4.6% |
| Nov 3, 2022 | ended Sep 2022 | $2.1B (+26% vs a year earlier) | — | +5.3% | +21.9% |
| Aug 2, 2022 | ended Jun 2022 | $2.0B (+25% vs a year earlier) | — | +5.9% | −1.7% |
| May 9, 2022 | ended Mar 2022 | $1.8B (+26% vs a year earlier) | — | +1.0% | −2.4% |
| Feb 3, 2022 | ended Dec 2021 | $1.8B (+30% vs a year earlier) | — | −7.4% | −5.2% |
Change in closing price from the first day shown, or with Price the closing price itself. Prices: Yahoo Finance, to Nov 12, 2026. Dashed lines: the days the company released earnings (its SEC 8-K filings); EPS estimates: Yahoo Finance. The stock's move after a release runs from the last close before its day to the close the day after (or five days after), so a release before the open counts like one after the close.
Is the business growing?
Revenue was $1.6B in the quarter ended Sep 2026, up 42% from a year earlier.
Show the data
| Quarter ended | Revenue | vs a year earlier |
|---|---|---|
| Dec 2022 | $2.2B | +23% |
| Mar 2023 | $2.2B | +21% |
| Jun 2023 | $2.3B | +17% |
| Sep 2023 | $2.3B | +9% |
| Dec 2023 | $1.8B | −19% |
| Mar 2024 | $1.3B | −41% |
| Jun 2024 | $1.2B | −46% |
| Sep 2024 | $1.2B | −48% |
| Dec 2024 | $1.0B | −42% |
| Mar 2025 | $970M | −27% |
| Jun 2025 | $1.1B | −13% |
| Sep 2025 | $1.1B | −2% |
| Dec 2025 | $1.2B | +16% |
| Mar 2026 | $1.3B | +35% |
| Jun 2026 | $1.5B | +38% |
| Sep 2026 | $1.6B | +42% |
Revenue went from $8.4B in FY23 to $4.7B in FY26; net income from $2.2B to $230M.
Show the data
| Fiscal year | Revenue | Net income |
|---|---|---|
| FY23 | $8.4B | $2.2B |
| FY24 | $7.6B | $1.9B |
| FY25 | $4.4B | −$500K |
| FY26 | $4.7B | $230M |
In the fiscal year to Mar 2026, Mixed-signal Microcontrollers was 50% and Analog was 28% of revenue; Mixed-signal Microcontrollers fell from 56% in the fiscal year to Mar 2024.
Show the data
| Fiscal year | Part | Revenue | Share |
|---|---|---|---|
| FY2024 | Mixed-signal Microcontrollers | $4.3B | 56% |
| FY2024 | Analog | $2.0B | 26% |
| FY2024 | Other | $1.3B | 18% |
| FY2025 | Mixed-signal Microcontrollers | $2.2B | 51% |
| FY2025 | Analog | $1.2B | 26% |
| FY2025 | Other | $995M | 23% |
| FY2026 | Mixed-signal Microcontrollers | $2.4B | 50% |
| FY2026 | Analog | $1.3B | 28% |
| FY2026 | Other | $1.0B | 22% |
A year earlier $0.03
Diluted, from SEC filings
Quarters: Microchip Technology Incorporated's SEC filings, named by the month they end. Fiscal years: Microchip Technology Incorporated's annual reports to the SEC.
How it makes money
Of every $100 in revenue, $4.9 ends up as net income. Net margin fell from 26.5% to 4.9% over the past 3 years.
Show the data
| Quarter ended | Gross | Operating | Net |
|---|---|---|---|
| Dec 2022 | 67.8% | 37.4% | 26.8% |
| Mar 2023 | 68.0% | 38.0% | 27.1% |
| Jun 2023 | 68.1% | 39.5% | 29.1% |
| Sep 2023 | 67.8% | 39.3% | 29.6% |
| Dec 2023 | 63.4% | 30.0% | 23.7% |
| Mar 2024 | 59.6% | 19.1% | 11.7% |
| Jun 2024 | 59.4% | 17.7% | 10.4% |
| Sep 2024 | 57.4% | 12.6% | 6.7% |
| Dec 2024 | 54.7% | 3.0% | −5.2% |
| Mar 2025 | 51.6% | −10.3% | −15.9% |
| Jun 2025 | 53.6% | 3.0% | −1.7% |
| Sep 2025 | 55.9% | 7.8% | 3.7% |
| Dec 2025 | 59.6% | 12.8% | 5.3% |
| Mar 2026 | 61.0% | 16.6% | 11.0% |
| Jun 2026 | 63.2% | 22.7% | 15.5% |
| Sep 2026 | 65.9% | 28.6% | 24.8% |
−9.8 pts over 3 years
−26.5 pts over 3 years
−21.6 pts over 3 years
Each margin is that line of the income statement divided by revenue. Fiscal year: Microchip Technology Incorporated's annual reports to the SEC; quarters: SEC filings.
Where it is in the chip cycle
Gross margin 65.9% and rising for 4 quarters; inventory at 190 days, down from 244 a year earlier; capital spending 1.3% of revenue over the last 4 quarters.
Show the data
| Period | Inventory days |
|---|---|
| FY23 | 176 |
| FY24 | 182 |
| FY25 | 244 |
| FY26 | 190 |
How many days of sales are sitting in stock. Rising inventory days often come before a downturn: chips are being made faster than they sell.
Show the data
| Period | Capital spending |
|---|---|
| Sep ’25 | 3.2% |
| Dec ’25 | 1.9% |
| Mar ’26 | 1.1% |
| Jun ’26 | 0.9% |
| Sep ’26 | 1.4% |
Money put into factories and equipment. Heavy spending late in an upswing can leave the industry with too much capacity when demand cools.
Gross margin by fiscal quarter, from SEC filings. Inventory days: year-end inventory over that year's cost of revenue, times 365.
Customers and suppliers
In its latest annual report Microchip Technology buys from SMIC; sells to Arrow Electronics.
Suppliers
Customers
Microchip Technology's 10-K for the year to Mar 2026 gives one customer's share of its revenue: Arrow Electronics (12%).
Show the filings' numbers
| Period | Customer | Share of revenue | Filing |
|---|---|---|---|
| Year ended Mar 2024 | Arrow Electronics | 12% | 10-K filed May 21, 2026 |
| Year ended Mar 2025 | Arrow Electronics | 10% | 10-K filed May 21, 2026 |
| Year ended Mar 2026 | Arrow Electronics | 12% | 10-K filed May 21, 2026 |
From Microchip Technology Incorporated's 10-Q and 10-K filings (XBRL): each customer whose share of revenue a filing tags, under the filing's own label, so “Customer A” in one filing can be another company in the next; a later filing's figures for a period replace an earlier one's.
Changes since the previous annual report (10-K filed May 23, 2025)
Show the filing's words
| Company | Role | In the filing's words |
|---|---|---|
| Arrow Electronics | customer | “With the exception of Arrow Electronics, the Company's largest distributor, which accounted for 12%, 10% and 12% of net sales in fiscal 2026, fiscal 2025 and fiscal 2024, respectively, no other distributor or direct customer accounted for more than 10% of net sales in either of fiscal 2026, fiscal 2025 or fiscal 2024.” |
| SMIC | supplier | “Some of our products are manufactured at SMIC, and some of our suppliers buy products manufactured at YMTC.” |
Only the companies Microchip Technology names in its 10-K filed May 21, 2026 (SEC). The supply chain joins the latest annual reports of the companies on it and the 8-Ks they filed since: a link shows when either side's report names the other, so it grows as more reports are read. Hover a name for the filing's own words.
Is it expensive?
P/E of 46.7x, above the peer median of 21x, so it needs earnings to keep growing to hold up.
Priced 122% above the peer median of 21x.
Show the data
| Company | P/E (trailing) |
|---|---|
| AMD · Advanced Micro Devices, Inc. | 127× |
| MCHP · Microchip Technology Incorporated | 46.7× |
| AVGO · Broadcom Inc. | 46.5× |
| NVDA · NVIDIA Corporation | 21× |
| MU · Micron Technology, Inc. | 10.8× |
| SKHY · SK hynix Inc. | 8.8× |
At 46.7× trailing earnings MCHP is inside the middle of its five-year range; the five-year median is 27.1×.
Show the data
| Date | Trailing P/E |
|---|---|
| Nov 8, 2021 | 72.6× |
| Feb 8, 2022 | 44.1× |
| May 10, 2022 | 30.1× |
| Aug 10, 2022 | 26.0× |
| Nov 8, 2022 | 20.7× |
| Feb 9, 2023 | 23.0× |
| May 11, 2023 | 18.2× |
| Aug 11, 2023 | 18.9× |
| Nov 9, 2023 | 16.2× |
| Feb 12, 2024 | 19.6× |
| May 13, 2024 | 26.6× |
| Aug 13, 2024 | 31.5× |
| Nov 11, 2024 | 48.5× |
| Feb 13, 2025 | 95.2× |
| May 15, 2026 | 427× |
| Aug 17, 2026 | 118× |
| Nov 12, 2026 | 46.7× |
Closing price over diluted earnings per share of the last four reported quarters, as known on each day (a quarter counts 35 days after it ends). From SEC filings; earnings per share adjusted for splits.
What analysts expect
The average analyst price target is $86.48, 39% above the current price; 81% of 26 analysts rate it a buy; earnings beat estimates in all of the last 4 quarters.
Buy or Strong Buy: 21 analysts (81%). Sell or Strong Sell: 0.
Over the past year the average of the analysts' latest price targets went from $75.29 to $89.65 (+19%), while MCHP went from $54.81 to $62.08 (+13%). In the past three months targets were cut 17 times and never raised. 1 upgrade and no downgrades over the year; the latest: Cantor Fitzgerald moved it to Overweight from Neutral on Dec 16, 2025.
Show every change
| Date | Firm | Change | Rating | Target |
|---|---|---|---|---|
| Nov 9, 2026 | Morgan Stanley | Target cut | Equal-Weight | $72.00, was $103.00 |
| Nov 9, 2026 | Barclays | Target cut | Equal-Weight | $90.00, was $105.00 |
| Nov 7, 2026 | JP Morgan | Target cut | Overweight | $100.00, was $120.00 |
| Nov 7, 2026 | Jefferies | Target cut | Buy | $85.00, was $100.00 |
| Nov 6, 2026 | Citigroup | Target cut | Buy | $75.00, was $95.00 |
| Nov 6, 2026 | Truist Securities | Target cut | Hold | $62.00, was $90.00 |
| Nov 6, 2026 | B. Riley Securities | Target cut | Buy | $85.00, was $98.00 |
| Nov 6, 2026 | Wells Fargo | Target cut | Equal-Weight | $70.00, was $80.00 |
| Nov 6, 2026 | Evercore ISI Group | Target cut | Outperform | $75.00, was $117.00 |
| Nov 6, 2026 | Keybanc | Target cut | Overweight | $120.00, was $135.00 |
| Nov 6, 2026 | Susquehanna | Target cut | Positive | $100.00, was $120.00 |
| Nov 6, 2026 | Cantor Fitzgerald | Target cut | Overweight | $100.00, was $125.00 |
| Nov 6, 2026 | Needham | Target cut | Buy | $85.00, was $120.00 |
| Nov 6, 2026 | Rosenblatt | Target cut | Buy | $115.00, was $120.00 |
| Oct 22, 2026 | B. Riley Securities | Target cut | Buy | $98.00, was $108.00 |
| Oct 20, 2026 | Wells Fargo | Target cut | Equal-Weight | $80.00, was $88.00 |
| Oct 19, 2026 | TD Cowen | Target cut | Hold | $75.00, was $90.00 |
| Aug 21, 2026 | BMO Capital | Began coverage | Outperform | $95.00 |
| Aug 17, 2026 | Cantor Fitzgerald | Target kept | Overweight | $125.00 |
| Aug 7, 2026 | UBS | Target cut | Buy | $120.00, was $130.00 |
| Aug 7, 2026 | Citigroup | Target cut | Buy | $95.00, was $113.00 |
| Aug 7, 2026 | Truist Securities | Target cut | Hold | $90.00, was $105.00 |
| Aug 7, 2026 | Rosenblatt | Target kept | Buy | $120.00 |
| Aug 3, 2026 | Cantor Fitzgerald | Target kept | Overweight | $125.00 |
| Jul 20, 2026 | Wells Fargo | Target cut | Equal-Weight | $88.00, was $95.00 |
| Jul 13, 2026 | TD Cowen | Target cut | Hold | $90.00, was $105.00 |
| May 13, 2026 | Cantor Fitzgerald | Target kept | Overweight | $125.00 |
| May 11, 2026 | Barclays | Target raised | Equal-Weight | $105.00, was $80.00 |
| May 8, 2026 | UBS | Target raised | Buy | $130.00, was $115.00 |
| May 8, 2026 | Citigroup | Target raised | Buy | $113.00, was $91.00 |
| May 8, 2026 | JP Morgan | Target raised | Overweight | $120.00, was $95.00 |
| May 8, 2026 | Truist Securities | Target raised | Hold | $105.00, was $69.00 |
| May 8, 2026 | Wells Fargo | Target raised | Equal-Weight | $95.00, was $75.00 |
| May 8, 2026 | Evercore ISI Group | Target raised | Outperform | $117.00, was $93.00 |
| May 8, 2026 | Susquehanna | Target raised | Positive | $120.00, was $95.00 |
| May 8, 2026 | Rosenblatt | Target raised | Buy | $120.00, was $115.00 |
| May 8, 2026 | Needham | Target raised | Buy | $120.00, was $84.00 |
| Feb 13, 2026 | Barclays | Began coverage | Equal-Weight | $80.00 |
| Feb 11, 2026 | Truist Securities | Target raised | Hold | $69.00, was $68.00 |
| Feb 6, 2026 | JP Morgan | Target raised | Overweight | $95.00, was $85.00 |
| Feb 6, 2026 | Citigroup | Target cut | Buy | $91.00, was $92.00 |
| Feb 6, 2026 | Wells Fargo | Target raised | Equal-Weight | $70.00, was $68.00 |
| Feb 6, 2026 | Truist Securities | Target raised | Hold | $68.00, was $60.00 |
| Feb 6, 2026 | Cantor Fitzgerald | Target kept | Overweight | $100.00 |
| Feb 6, 2026 | Mizuho | Target raised | Outperform | $90.00, was $83.00 |
| Feb 6, 2026 | Rosenblatt | Target raised | Buy | $115.00, was $80.00 |
| Feb 6, 2026 | Needham | Target raised | Buy | $84.00, was $77.00 |
| Feb 2, 2026 | Cantor Fitzgerald | Target raised | Overweight | $100.00, was $85.00 |
| Jan 26, 2026 | UBS | Target raised | Buy | $95.00, was $85.00 |
| Jan 22, 2026 | Susquehanna | Target raised | Positive | $90.00, was $75.00 |
| Jan 21, 2026 | B of A Securities | Target raised | Neutral | $78.00, was $72.00 |
| Jan 15, 2026 | Citigroup | Target raised | Buy | $92.00, was $80.00 |
| Jan 15, 2026 | Piper Sandler | Target raised | Overweight | $85.00, was $80.00 |
| Jan 12, 2026 | B. Riley Securities | Target raised | Buy | $95.00, was $85.00 |
| Jan 9, 2026 | Mizuho | Target raised | Outperform | $83.00, was $80.00 |
| Jan 7, 2026 | Wells Fargo | Target raised | Equal-Weight | $68.00, was $58.00 |
| Jan 6, 2026 | JP Morgan | Target raised | Overweight | $85.00, was $77.00 |
| Jan 6, 2026 | Morgan Stanley | Target raised | Equal-Weight | $69.00, was $68.00 |
| Jan 6, 2026 | Rosenblatt | Target kept | Buy | $80.00 |
| Jan 6, 2026 | Stifel | Target raised | Buy | $80.00, was $75.00 |
| Jan 6, 2026 | Needham | Target raised | Buy | $77.00, was $75.00 |
| Dec 16, 2025 | Cantor Fitzgerald | Upgrade | Overweight, was Neutral | $85.00, was $65.00 |
| Dec 5, 2025 | B of A Securities | Target raised | Neutral | $72.00, was $67.00 |
| Dec 4, 2025 | Needham | Target raised | Buy | $75.00, was $73.00 |
| Dec 3, 2025 | Rosenblatt | Target kept | Buy | $80.00 |
Show the data
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec ’25 | $0.43 | $0.44 | +2.3% |
| Mar ’26 | $0.50 | $0.57 | +14.0% |
| Jun ’26 | $0.70 | $0.76 | +8.6% |
| Sep ’26 | $0.94 | $0.97 | +3.2% |
The day after each of these reports the stock moved −2.8% (Dec 2025, beat); −3.7% (Mar 2026, beat); +8.9% (Jun 2026, beat); −22.6% (Sep 2026, beat).
For the quarter ending Dec 2026 (Microchip Technology reports on Feb 4, 2027), analysts expect adjusted earnings of $0.91 a share, 107% more than the $0.44 of a year earlier, and revenue of $1.6B, up 36% on a year earlier. For the fiscal year ending Mar 2027, they expect adjusted earnings of $3.63 a share, and revenue of $6.4B, up 35% on the year before.
Adjusted. Dec 2025: $0.44; range $0.90 to $0.95; 22 analysts
Dec 2025: $1.2B; range $1.6B to $1.6B; 20 analysts
Adjusted. Range $3.57 to $3.86; 23 analysts
The year to Mar 2026: $4.7B; range $6.3B to $6.4B; 23 analysts
Show the data
| Period | Figure | Expected | Low to high | Analysts | A year earlier | Change |
|---|---|---|---|---|---|---|
| Quarter ending Dec 2026, results Feb 4, 2027 | EPS (adjusted) | $0.91 | $0.90 to $0.95 | 22 | $0.44 (Dec 2025) | +107% |
| Quarter ending Dec 2026, results Feb 4, 2027 | Revenue | $1.6B | $1.6B to $1.6B | 20 | $1.2B (Dec 2025) | +36% |
| Quarter ending Mar 2027 | EPS (adjusted) | $0.96 | $0.92 to $1.02 | 22 | $0.57 (Mar 2026) | +68% |
| Quarter ending Mar 2027 | Revenue | $1.7B | $1.6B to $1.8B | 21 | $1.3B (Mar 2026) | +28% |
| Year ending Mar 2027 | EPS (adjusted) | $3.63 | $3.57 to $3.86 | 23 | — | — |
| Year ending Mar 2027 | Revenue | $6.4B | $6.3B to $6.4B | 23 | $4.7B (year to Mar 2026) | +35% |
| Year ending Mar 2028 | EPS (adjusted) | $4.44 | $4.09 to $4.91 | 25 | $3.63 (expected, year to Mar 2027) | +23% |
| Year ending Mar 2028 | Revenue | $7.4B | $6.9B to $8.4B | 23 | $6.4B (expected, year to Mar 2027) | +16% |
Targets, ratings and earnings estimates: Yahoo Finance. Rating and target changes: Yahoo Finance's list of upgrades and downgrades. The average target on each day is the average of every listed firm's latest target set in the 180 days before it, so it counts fewer analysts than the average target above, and the band is the middle half of those targets (a quarter of the firms are above it, a quarter below); a target set before a stock split is divided by the split. Expected figures: the average of the analysts' estimates (Yahoo Finance). Their EPS is adjusted, as analysts estimate it, so it is set against the adjusted EPS Yahoo reports for the same quarters, not the GAAP EPS of the growth and valuation sections; revenue against the SEC filings. No change is given against a quarter whose reported EPS was more than 50% off its own estimate (often a one-off gain or charge), nor against a year that counts one. Each estimate is pinned to its fiscal period by the report date or the period's end, and one that cannot be is left out.
Where the cash goes
Generated $1.5B in free cash flow over the year, of which $990M went back to shareholders (dividends plus buybacks), leaving $470M in the company.
Show the data
| Line | Amount |
|---|---|
| Op. cash flow | $1.5B |
| Capex | −$70M |
| Free cash flow | $1.5B |
| Dividends | −$990M |
| Buybacks | — |
| Cash retained | $470M |
For every $100 of market cap, the company generates about $4.3 in free cash flow a year.
For every $100 of market cap, you receive about $2.9 in dividends a year.
Show the data
| Quarter ended | Free cash flow | Dividends | Buybacks |
|---|---|---|---|
| Dec 2023 | $794M | $237M | $115M |
| Mar 2024 | $390M | $242M | $387M |
| Jun 2024 | $304M | $243M | $73M |
| Sep 2024 | $23M | $244M | $17M |
| Dec 2024 | $253M | $245M | $6.5M |
| Mar 2025 | $192M | $245M | $0 |
| Jun 2025 | $258M | $246M | $0 |
| Sep 2025 | $52M | $246M | $0 |
| Dec 2025 | $319M | $246M | $0 |
| Mar 2026 | $243M | $247M | $0 |
| Jun 2026 | $498M | $247M | — |
| Sep 2026 | $396M | $248M | — |
Microchip Technology had 551M diluted shares in the quarter ended Sep 2026, 1.0% more than a year earlier, and 0.6% fewer each year on average since Dec 2021.
Show the data
| Quarter ended | Diluted shares |
|---|---|
| Dec 2021 | 567M |
| Jun 2022 | 562M |
| Sep 2022 | 558M |
| Dec 2022 | 555M |
| Jun 2023 | 551M |
| Sep 2023 | 549M |
| Dec 2023 | 546M |
| Jun 2024 | 543M |
| Sep 2024 | 542M |
| Dec 2024 | 537M |
| Jun 2025 | 539M |
| Sep 2025 | 545M |
| Dec 2025 | 546M |
| Jun 2026 | 550M |
| Sep 2026 | 551M |
Free cash flow: operating cash flow minus capital spending on property, plant and equipment, from SEC filings, for the last 4 quarters and by quarter. Shares: each quarter's diluted weighted average as filed with the SEC, since the stock's listing and its latest split.
Financial health
Current ratio 2.1, no pressure to repay short-term debt; debt-to-equity 0.9, debt is moderate.
Assets that can be turned into cash soon are 2.1x what is owed within a year. 1.5 or higher is comfortable; below 1 needs watching.
For every $1 of shareholder funds, there is $0.9 of debt (leases not counted). The higher the number, the more pressure when the economy weakens.
Cash and short-term investments of $240M against debt of $5.5B. Lease obligations of $39M are not counted: they are rent owed, not money borrowed.
Latest fiscal year balance sheet. Source: Yahoo Finance.
Who holds it
In the filings of 1 member of Congress and 7 funds whose copy leaves MCHP out (not traded on the exchange): Mirae Asset Global Investments, Bridgewater Associates, Norges Bank, Swiss National Bank, Canada Pension Plan Investment Board, Rob Bresnahan and 2 more.
What did the funds Hunch tracks do?
Of the 83 funds whose 13F filings Hunch reads, 14 held MCHP at the end of their latest quarter (for most, Q2 2026). Over that quarter 6 added shares, 5 cut, 3 bought new and 1 sold all. The largest of them is Norges Bank, 9.08M shares worth $828M at Jun 30, 2026, 12.9% fewer than at Dec 31, 2025.
3 of them new holders
1 of them sold all
Show every fund
| Fund | Quarter | Shares | Value | Change in shares | Change | Filed |
|---|---|---|---|---|---|---|
| Norges Bank | Q2 2026 vs Q4 2025 | 9.08M | $828M | −1.35M | −13% | Aug 12, 2026 |
| Dodge & Cox | Q2 2026 | 5.53M | $505M | −596,357 | −9.7% | Aug 13, 2026 |
| Renaissance Technologies | Q3 2026 | 1.71M | $133M | +668,300 | +64% | Nov 12, 2026 |
| Swiss National Bank | Q3 2026 | 1.49M | $116M | −41,100 | −2.7% | Nov 12, 2026 |
| Mirae Asset Global Investments | Q3 2026 | 1.21M | $94.3M | +153,514 | +14% | Nov 3, 2026 |
| National Pension Service | Q3 2026 | 914,206 | $71.1M | +22,369 | +2.5% | Nov 12, 2026 |
| Canada Pension Plan Investment Board | Q2 2026 | 451,728 | $41.2M | −361,082 | −44% | Aug 14, 2026 |
| Korea Investment | Q2 2026 | 361,117 | $32.9M | +88,079 | +32% | Aug 12, 2026 |
| Nomura Holdings | Q2 2026 | 329,589 | $30.1M | −11,826 | −3.5% | Aug 14, 2026 |
| Bridgewater Associates | Q2 2026 | 275,882 | $25.2M | +246,941 | +853% | Aug 14, 2026 |
| Glenview Capital Management | Q2 2026 | 265,577 | $24.2M | +265,577 | New | Aug 14, 2026 |
| Soros Fund Management | Q2 2026 | 227,800 | $20.8M | +227,800 | New | Aug 14, 2026 |
| Tudor Investment Corp Et Al | Q2 2026 | 0 | — | −151,836 | Sold all | Aug 14, 2026 |
| Maverick Capital | Q2 2026 | 7,205 | $657K | +7,205 | New | Aug 14, 2026 |
| Fisher Asset Management | Q3 2026 | 3,615 | $281K | +229 | +6.8% | Nov 6, 2026 |
From the 13F filings of the 83 funds Hunch tracks, not of every institution: each fund's shares of MCHP at its latest quarter end against the quarter before, as filed (long positions only, options left out), the quarter before put on the latest quarter's share count across a split. A fund files 45 days after its quarter ends, so some have a newer quarter than others. Value is at the quarter end. Norges Bank filed its 13F for Q1 2026 confidentially, with no holdings made public, so its row compares Q2 2026 with Q4 2025.